Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Artificial Intelligence (AI) in Medicine market: $3.5 Bn against $664 Mn in 2023, about 5.3 times as large.
Canada grows faster: 37.5% a year, against 35.5%. The gap still grows from $2.8 Bn to $56.7 Bn by 2033.
Clinical research: 642 active trials in the US, 103 in Canada.
| Measure | ||
|---|---|---|
| Market size, 2023 | $3.5 Bn | $664 Mn |
| Market size, 2033 projected | $72.7 Bn | $16 Bn |
| Growth a year (CAGR) | 35.5% | 37.5% |
| Money added, 2023–2033 | $69.2 Bn | $15.4 Bn |
| Size rank of 24 countries | #1 | #3 |
| Market per person, 2023 | $10 | $16 |
| Active clinical trials | 642 | 103 |
| Full report | US report | Canada report |
US Canada · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Artificial Intelligence (AI) in Medicine market: $3.5 Bn against $664 Mn in 2023, about 5.3 times as large.
Canada grows faster: 37.5% a year, against 35.5%. The gap still grows from $2.8 Bn to $56.7 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.